Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial looked at a drug called elacytarabine (pronounced el-ah-site-ar-ah-been) for people with acute myeloid leukaemia (AML). It was for people with AML that had come back or did not respond to treatment.
Recruitment start: 17 August 2010
Recruitment end: 6 December 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Francis Giles Dr Gail Roboz
Clavis Pharma
NIHR Clinical Research Network: Cancer
Last reviewed: 27 November 2014
CRUK internal database number: 7294
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
